Other technical consultancy
IMMUVERA THERAPEUTICS AS
Revenue 2024
NOK 220,000
Operating profit
NOK −5.9m
Equity
NOK 15.8m
Incorporated
2020
Share capital
NOK 69,000
Key figures · 2024
Current ratio
2.85
Equity ratio
76.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -2681.0% | |
| Net margin (%%) | -2685.2% | |
| Return on assets (%%) | -28.7% | |
| Likviditet | ||
| Current ratio | 2.85 | |
| Working capital | 3.4m | |
| Soliditet | ||
| Equity ratio (%%) | 76.9% | |
| Debt-to-equity ratio | 0.30 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.